CNGA1
Cyclic nucleotide-gated channel alpha-1
Also known as: CNCG, CNCG1, CNG1, CNGA1_HUMAN, RCNC1, RCNCa, RP49
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29973
- Gene
- CNGA1
- Ensembl
- ENSG00000198515
- Chromosome
- 4
- Canonical length
- 686 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane,Mitotic spindle,Primary cilium,Primary cilium tip,Mid piece,Principal piece
OverviewNCBI Gene
The protein encoded by this gene is involved in phototransduction. Along with another protein, the encoded protein forms a cGMP-gated cation channel in the plasma membrane, allowing depolarization of rod photoreceptors. This represents the last step in the phototransduction pathway. Defects in this gene are a cause of retinitis pigmentosa autosomal recessive (ARRP) disease. Multiple transcript variants have been found for this gene. [provided by RefSeq, Oct 2019]
Canonical amino-acid sequenceUniProt
686 residues, UniProt reviewed canonical sequence.
>P29973|CNGA1
1 MKNNIINTQQ SFVTMPNVIV PDIEKEIRRM ENGACSSFSE DDDSASTSEE SENENPHARG
61 SFSYKSLRKG GPSQREQYLP GAIALFNVNN SSNKDQEPEE KKKKKKEKKS KSDDKNENKN
121 DPEKKKKKKD KEKKKKEEKS KDKKEEEKKE VVVIDPSGNT YYNWLFCITL PVMYNWTMVI
181 ARACFDELQS DYLEYWLILD YVSDIVYLID MFVRTRTGYL EQGLLVKEEL KLINKYKSNL
241 QFKLDVLSLI PTDLLYFKLG WNYPEIRLNR LLRFSRMFEF FQRTETRTNY PNIFRISNLV
301 MYIVIIIHWN ACVFYSISKA IGFGNDTWVY PDINDPEFGR LARKYVYSLY WSTLTLTTIG
361 ETPPPVRDSE YVFVVVDFLI GVLIFATIVG NIGSMISNMN AARAEFQARI DAIKQYMHFR
421 NVSKDMEKRV IKWFDYLWTN KKTVDEKEVL KYLPDKLRAE IAINVHLDTL KKVRIFADCE
481 AGLLVELVLK LQPQVYSPGD YICKKGDIGR EMYIIKEGKL AVVADDGVTQ FVVLSDGSYF
541 GEISILNIKG SKAGNRRTAN IKSIGYSDLF CLSKDDLMEA LTEYPDAKTM LEEKGKQILM
601 KDGLLDLNIA NAGSDPKDLE EKVTRMEGSV DLLQTRFARI LAEYESMQQK LKQRLTKVEK
661 FLKPLIDTEF SSIEGPGAES GPIDSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CNGA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 245 nTPM
Expression across tissuesHPA
Tissue
- retina: 245 nTPM
- liver: 22 nTPM
- epididymis: 8.8 nTPM
- esophagus: 8.4 nTPM
- small intestine: 5.8 nTPM
- skin: 4.7 nTPM
Single-cell type
- rod photoreceptor cells: 1,025 nCPM
- esophageal apical cells: 337 nCPM
- renal collecting duct principal cells: 164 nCPM
- urothelial cells: 133 nCPM
- breast lactating cells: 125 nCPM
- papillary tip epithelial cells: 100 nCPM
Immune cell
- plasmacytoid DC: 0.5 nTPM
- memory CD8 T-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
- neutrophil: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- cerebellum: 3.9 nTPM
- basal ganglia: 3.6 nTPM
- cerebral cortex: 2.4 nTPM
- hypothalamus: 2.4 nTPM
- choroid plexus: 2 nTPM
- white matter: 1.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CNGA1.
Disease | AllUniProt
Conditions CNGA1 is implicated in, by any mechanism.
- Retinitis pigmentosa 49 (RP49) MIM:613756
Disease | GeneticClinVar
82 pathogenic / likely-pathogenic of 536 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Retinitis pigmentosa 49
- Retinitis pigmentosa
- Retinal dystrophy
- CNGA1-related disorder
- Retinal disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.44
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transport
- monoatomic cation transmembrane transport
- sensory perception of chemical stimulus
- sodium ion transport
- visual perception
Molecular functions
- calcium channel activity
- cAMP binding
- cGMP binding
- intracellularly cAMP-activated cation channel activity
- intracellularly cGMP-activated cation channel activity
- sodium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cyclic nucleotide-binding domain
- Ion transport domain
- RmlC-like jelly roll fold
- Cyclic nucleotide-binding, conserved site
- Cyclic nucleotide-binding domain superfamily
- Cyclic nucleotide-gated channel, C-terminal leucine zipper domain
- Cyclic nucleotide-gated cation channel
- Cyclic nucleotide-binding domain
- Ion transport protein
- C-terminal leucine zipper domain of cyclic nucleotide-gated channels
KeywordsUniProt
- Calcium
- Calcium channel
- Calcium transport
- cAMP
- cAMP-binding
- Cell membrane
- cGMP
- cGMP-binding
- Coiled coil
- Glycoprotein
- Ion channel
- Ion transport
- Ligand-gated ion channel
- Membrane
- Nucleotide-binding
- Retinitis pigmentosa
- Sensory transduction
- Sodium
- Sodium channel
- Sodium transport
- Transmembrane
- Transmembrane helix
- Transport
- Vision
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CNGA1 as an antibody target. Whether an autoantibody or antibody against CNGA1 could matter depends on whether native CNGA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CNGA1 is annotated at the cell surface, where native CNGA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CNGA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...